Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 28188133

PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2017 Apr 27
First author
Kwong YL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Apr 27;129(17):2342-2343. doi: 10.1182/blood-2017-03-769075.
    note
    Source null
    related pmid
    28450574
    relationship
    Comment in

Authors and identifiers

  1. name
    Kwong YL
    type
    Author
  2. name
    Chan TSY
    type
    Author
  3. name
    Tan D
    type
    Author
  4. name
    Kim SJ
    type
    Author
  5. name
    Poon LM
    type
    Author
  6. name
    Mow B
    type
    Author
  7. name
    Khong PL
    type
    Author
  8. name
    Loong F
    type
    Author
  9. name
    Au-Yeung R
    type
    Author
  10. name
    Iqbal J
    type
    Author
  11. name
    Phipps C
    type
    Author
  12. name
    Tse E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kwong YL
    type
    Author
  2. name
    Chan TSY
    type
    Author
  3. name
    Tan D
    type
    Author
  4. name
    Kim SJ
    type
    Author
  5. name
    Poon LM
    type
    Author
  6. name
    Mow B
    type
    Author
  7. name
    Khong PL
    type
    Author
  8. name
    Loong F
    type
    Author
  9. name
    Au-Yeung R
    type
    Author
  10. name
    Iqbal J
    type
    Author
  11. name
    Phipps C
    type
    Author
  12. name
    Tse E
    type
    Author
bibliography ids
  1. nci-bib-837c0c96c20e8cfabefe00c4
book metadata
content sha256
dc48e3f91aeb16a9619a5bbcdda878719739e9f331ed5fc973a597896f35f41b
document type
citation
dois
  1. 10.1182/blood-2016-12-756841
electronic publication date
display
2017 Feb 10
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28188133
immutable id
pubmed:28188133@dc48e3f91aeb16a9619a5bbcdda878719739e9f331ed5fc973a597896f35f41b
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
17
name
Blood
nlm unique id
7603509
pages
2437-2442
volume
129
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Apr 27;129(17):2342-2343. doi: 10.1182/blood-2017-03-769075.
    note
    Source null
    related pmid
    28450574
    relationship
    Comment in
outcomes validated
false
pmid
28188133
provenance
batch id
7a1288ac8bb5f9826304
provider
NCBI PubMed ESummary
record sha256
30745c87a464e47524b49b827ff6edfef565e6b452f8ec5d0ef0494c8bea44a7
response sha256
0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
retrieved at
2026-09-09T23:47:23.138359+00:00
publication date
display
2017 Apr 27
precision
day
year
2017
publication types
  1. Journal Article
  2. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28188133/
title
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.

Preserved source evidence · Independent clinical review pending · Not medical advice